• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

颗粒状tau寡聚体水平升高:脑衰老和阿尔茨海默病的早期迹象。

Increased levels of granular tau oligomers: an early sign of brain aging and Alzheimer's disease.

作者信息

Maeda Sumihiro, Sahara Naruhiko, Saito Yuko, Murayama Shigeo, Ikai Atsushi, Takashima Akihiko

机构信息

Lab for Alzheimer's Disease, Brain Science Institute, RIKEN, 2-1 Hirosaswa, Wako, Saitama 351-0198, Japan.

出版信息

Neurosci Res. 2006 Mar;54(3):197-201. doi: 10.1016/j.neures.2005.11.009. Epub 2006 Jan 6.

DOI:10.1016/j.neures.2005.11.009
PMID:16406150
Abstract

Development of neurofibrillary tangles (NFTs) is a pathological hallmark in various neurodegenerative disorders including Alzheimer's disease (AD). Recently, we identified a granular tau oligomer having a pre-filamentous structure. To determine the role of this oligomer in NFT formation, we quantified the amount of granular tau oligomer in 21 frontal cortex samples, each displaying varying degrees of Braak-staged NFT pathology. Here we report that granular tau oligomer levels in frontal cortex were significantly increased, even in brains displaying Braak-stage I neuropathology, a stage at which clinical symptoms of AD and NFTs in frontal cortex are believed to be absent. This suggests that increases in granular tau oligomer levels occur before NFTs form and before individuals manifest clinical symptoms of AD. Increased granular tau oligomer levels, therefore, may lead to NFT formation in frontal cortex, eventually leading to the development of AD. Thus, increases in granular tau oligomer levels may represent a very early sign of NFT formation and AD.

摘要

神经原纤维缠结(NFTs)的形成是包括阿尔茨海默病(AD)在内的各种神经退行性疾病的病理标志。最近,我们鉴定出一种具有丝状前结构的颗粒状tau寡聚体。为了确定这种寡聚体在NFT形成中的作用,我们对21个额叶皮质样本中的颗粒状tau寡聚体数量进行了定量,每个样本都表现出不同程度的Braak分期NFT病理。在此我们报告,即使在显示Braak I期神经病理学的大脑中,额叶皮质中的颗粒状tau寡聚体水平也显著增加,据信该阶段AD的临床症状和额叶皮质中的NFT不存在。这表明颗粒状tau寡聚体水平的增加发生在NFT形成之前以及个体出现AD临床症状之前。因此,颗粒状tau寡聚体水平的增加可能导致额叶皮质中NFT的形成,最终导致AD的发展。因此,颗粒状tau寡聚体水平的增加可能代表NFT形成和AD的非常早期迹象。

相似文献

1
Increased levels of granular tau oligomers: an early sign of brain aging and Alzheimer's disease.颗粒状tau寡聚体水平升高:脑衰老和阿尔茨海默病的早期迹象。
Neurosci Res. 2006 Mar;54(3):197-201. doi: 10.1016/j.neures.2005.11.009. Epub 2006 Jan 6.
2
Granular tau oligomers as intermediates of tau filaments.颗粒状tau寡聚体作为tau细丝的中间体。
Biochemistry. 2007 Mar 27;46(12):3856-61. doi: 10.1021/bi061359o. Epub 2007 Mar 6.
3
[Drug development for tauopathy and Alzheimer's disease].[针对tau蛋白病和阿尔茨海默病的药物研发]
Nihon Shinkei Seishin Yakurigaku Zasshi. 2010 Aug;30(4):177-80.
4
[Significance of tau in the development of Alzheimer's disease].[tau蛋白在阿尔茨海默病发展中的意义]
Brain Nerve. 2010 Jul;62(7):701-8.
5
Molecular chaperone-mediated tau protein metabolism counteracts the formation of granular tau oligomers in human brain.分子伴侣介导的tau蛋白代谢可对抗人脑中颗粒状tau寡聚体的形成。
J Neurosci Res. 2007 Nov 1;85(14):3098-108. doi: 10.1002/jnr.21417.
6
Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins).人类大脑中神经原纤维病变丰富的区域,其具有结合能力的tau蛋白水平会选择性降低,且异常tau异构体(A68蛋白)会积累。
Lab Invest. 1992 Feb;66(2):212-22.
7
Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.阿尔茨海默病中基于非tau蛋白的神经元变性——颞中回新皮质颗粒上层的免疫细胞化学和定量研究
Brain Res. 2008 Jun 5;1213:152-65. doi: 10.1016/j.brainres.2008.03.043. Epub 2008 Apr 1.
8
Tau protein abnormalities associated with the progression of alzheimer disease type dementia.与阿尔茨海默病型痴呆进展相关的tau蛋白异常。
Neurobiol Aging. 2007 Jan;28(1):1-7. doi: 10.1016/j.neurobiolaging.2005.11.001. Epub 2005 Dec 15.
9
14-3-3 proteins and zeta isoform containing neurofibrillary tangles in patients with Alzheimer's disease.阿尔茨海默病患者中含有神经原纤维缠结的14-3-3蛋白和ζ亚型
Acta Neuropathol. 2004 Oct;108(4):279-86. doi: 10.1007/s00401-004-0885-4. Epub 2004 Jul 2.
10
The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset?在阿尔茨海默病中,中缝背核在内嗅区之前就出现了磷酸化tau神经原纤维变化。发病提前?
Neuropathol Appl Neurobiol. 2009 Aug;35(4):406-16. doi: 10.1111/j.1365-2990.2009.00997.x.

引用本文的文献

1
Tau Oligomers in Alzheimer's Disease: Modulation Effect of Osmolytes on Amplified Brain-Derived Tau Oligomers.阿尔茨海默病中的tau寡聚体:渗透剂对脑源性tau寡聚体扩增的调节作用
ACS Chem Neurosci. 2025 Aug 6;16(15):2829-2843. doi: 10.1021/acschemneuro.5c00122. Epub 2025 Jul 18.
2
Polyamination with spermidine enhances pathogenic tau conformations while reducing filamentous aggregate formation in vitro.用亚精胺进行多胺化反应可增强致病性tau构象,同时在体外减少丝状聚集体的形成。
Biochem J. 2025 Jun 17;482(12):877-99. doi: 10.1042/BCJ20253079.
3
Novel strategies for targeting tau oligomers in neurodegenerative diseases.
针对神经退行性疾病中tau寡聚体的新策略。
J Neurol. 2025 May 8;272(6):383. doi: 10.1007/s00415-025-13117-w.
4
Tau aggregation induces cell death in iPSC-derived neurons.Tau蛋白聚集在诱导多能干细胞衍生的神经元中引发细胞死亡。
Aging Brain. 2025 Apr 11;7:100136. doi: 10.1016/j.nbas.2025.100136. eCollection 2025.
5
O-GlcNAc modification differentially regulates microtubule binding and pathological conformations of tau isoforms in vitro.O-连接的N-乙酰葡糖胺修饰在体外差异调节微管结合及tau异构体的病理构象。
J Biol Chem. 2025 Mar;301(3):108263. doi: 10.1016/j.jbc.2025.108263. Epub 2025 Feb 3.
6
High-molecular-weight oligomer tau (HMWoTau) species are dramatically increased in Braak-stage dependent manner in the frontal lobe of human brains, demonstrated by a novel oligomer Tau ELISA with a mouse monoclonal antibody (APNmAb005).高分子量寡聚体 tau(HMWoTau)物种在人类大脑额叶中以明显的 Braak 阶段依赖性方式增加,这是通过一种新型的寡聚 Tau ELISA 与小鼠单克隆抗体(APNmAb005)来证明的。
FASEB J. 2024 Nov 30;38(22):e70160. doi: 10.1096/fj.202401704R.
7
Marmosets as model systems for the study of Alzheimer's disease and related dementias: Substantiation of physiological tau 3R and 4R isoform expression and phosphorylation.狨猴作为阿尔茨海默病及相关痴呆症研究的模型系统:生理性tau 3R和4R亚型表达及磷酸化的确证
Alzheimers Dement. 2025 Jan;21(1):e14366. doi: 10.1002/alz.14366. Epub 2024 Nov 19.
8
Exploring the rhodanine universe: Design and synthesis of fluorescent rhodanine-based derivatives as anti-fibrillar and anti-oligomer agents against α-synuclein and 2N4R tau.探索若丹宁的世界:基于若丹宁的荧光衍生物的设计与合成,作为针对α-突触核蛋白和2N4R tau蛋白的抗纤维和抗寡聚体药物。
Bioorg Med Chem. 2024 Dec 15;116:117990. doi: 10.1016/j.bmc.2024.117990. Epub 2024 Nov 9.
9
Generation of nanobodies with conformational specificity for tau oligomers that recognize tau aggregates from human Alzheimer's disease samples.针对 tau 寡聚体具有构象特异性的纳米抗体的生成,可识别来自人类阿尔茨海默病样本的 tau 聚集物。
Biomater Sci. 2024 Nov 19;12(23):6033-6046. doi: 10.1039/d4bm00707g.
10
Mass spectrometry identifies tau C-terminal phosphorylation cluster during neuronal hyperexcitation.质谱法鉴定神经元过度兴奋期间的tau蛋白C末端磷酸化簇。
J Neurochem. 2025 Jan;169(1):e16221. doi: 10.1111/jnc.16221. Epub 2024 Sep 22.